Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer

被引：0
|
作者：
Jiyoung Keum
Hee Seung Lee
Huapyong Kang
Jung Hyun Jo
Moon Jae Chung
Jeong Youp Park
Seung Woo Park
Si Young Song
Seungmin Bang
机构：
[1] Yonsei University College of Medicine,Division of Gastroenterology, Department of Internal Medicine, Institute of Gastroenterology
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 85卷
关键词：
Pancreatic cancer; Chemotherapy; Neutropenia; Febrile neutropenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：651 / 659
页数：8
相关论文
共 50 条
  • [21] FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
    Cho, In Rae
    Kang, Huapyong
    Jo, Jung Hyun
    Lee, Hee Seung
    Chung, Moon Jae
    Park, Jeong Youp
    Park, Seung Woo
    Song, Si Young
    An, Chansik
    Park, Mi-Suk
    Bang, Seungmin
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (02) : 182 - 194
  • [22] FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
    In Rae Cho
    Huapyong Kang
    Jung Hyun Jo
    Hee Seung Lee
    Moon Jae Chung
    Jeong Youp Park
    Seung Woo Park
    Si Young Song
    Chansik An
    Mi-Suk Park
    Seungmin Bang
    World Journal of Gastrointestinal Oncology, 2020, 12 (02) : 182 - 194
  • [23] Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study
    Bhardwaj, Prarthna V.
    Emmich, Megan
    Knee, Alexander
    Ali, Fatima
    Walia, Ritika
    Roychowdhury, Prithwijit
    Clark, Jackson
    Sridhar, Arthi
    Lagu, Tara
    Loh, Kah Poh
    SUPPORTIVE CARE IN CANCER, 2021, 29 (10) : 5905 - 5914
  • [24] Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study
    Prarthna V. Bhardwaj
    Megan Emmich
    Alexander Knee
    Fatima Ali
    Ritika Walia
    Prithwijit Roychowdhury
    Jackson Clark
    Arthi Sridhar
    Tara Lagu
    Kah Poh Loh
    Supportive Care in Cancer, 2021, 29 : 5905 - 5914
  • [25] Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia:: A randomized, single-center phase II trial
    Engervall, P
    Kalin, M
    Dornbusch, K
    Björkholm, M
    JOURNAL OF CHEMOTHERAPY, 1999, 11 (04) : 278 - 286
  • [26] Predicting complications of chemotherapy-induced febrile neutropenia: A single-center experience.
    Bhosale, Bharatsinha Baburao
    Path, Vijay
    Muddu, Vamshi
    Singh, Randeep
    Dwivedi, Pankaj
    Noronha, Vanita
    Joshi, Amit
    Ghosh, Jaya
    Gupta, Sudeep
    Banavall, Shripad
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Analysis of bacteremia at first-line antibiotic treatment for febrile neutropenia in children and adolescents: A retrospective, single-center analysis
    Kobayashi, Ryoji
    Sano, Hirozumi
    Matsushima, Satoru
    Hori, Daiki
    Yanagi, Masato
    Suzuki, Daisuke
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (07) : 642 - 645
  • [28] Incidence of and risk factors for severe neutropenia during treatment with the modified FOLFIRINOX therapy in patients with advanced pancreatic cancer
    Ai Irisawa
    Misaki Takeno
    Kazuo Watanabe
    Hideaki Takahashi
    Shuichi Mitsunaga
    Masafumi Ikeda
    Scientific Reports, 12
  • [29] Modified FOLFIRINOX as neoadjuvant treatment in patients with borderline resectable and locally advanced pancreatic adenocarcinoma: A single-center study
    Ioannou, S.
    Papaxoinis, G.
    Korkolis, D.
    Kypreos, D.
    Gouveris, P.
    Zouki, D.
    Kardara, V.
    Exarchos, K.
    Karianakis, G.
    Bitsas, I.
    Adamou, V.
    Koronakis, G.
    Stavrou, N.
    Demiri, S.
    ANNALS OF ONCOLOGY, 2022, 33 : S301 - S301
  • [30] Incidence of and risk factors for severe neutropenia during treatment with the modified FOLFIRINOX therapy in patients with advanced pancreatic cancer
    Irisawa, Ai
    Takeno, Misaki
    Watanabe, Kazuo
    Takahashi, Hideaki
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345